Not yet recruitingPHASE2, PHASE3NCT07444723
Accuracy of 18F-Fluorocholine PET/MR and NeuroEXPLORER PET/CT Imaging for Localization of Parathyroid Tumors
Studying Parathyroid carcinoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Principal Investigator
- Smita Jha, M.D., M.DNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Intervention
- 18F-FCH(drug)
- Enrollment
- 193 enrolled
- Eligibility
- 18-100 years · All sexes
- Timeline
- 2026 – 2036
Study locations (1)
- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT07444723 on ClinicalTrials.govOther trials for Parathyroid carcinoma
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT06645951Institution of an Italian Multicenter Database of Patients with Parathyroid Carcinoma or Atypical Parathyroid AdenomaF.I.R.M.O. - Fondazione Italiana Ricerca sulle Malattie dell'Osso - Ente del Terzo Settore
- RECRUITINGPHASE2NCT06638931Agnostic Therapy in Rare Solid TumorsInstituto do Cancer do Estado de São Paulo
- RECRUITINGNANCT06835426High-resolution PET-CT Specimen Imaging for the Perioperative Visualization of Resection MarginsAlgemeen Ziekenhuis Maria Middelares
- RECRUITINGNCT04969926Natural History Study of Parathyroid DisordersNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)